Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Molecular and Cellular Endocrinology

Volumn 259, Issue 1-2, 2006, Pages 10-21

  Zheng, Rong ^a   Shen, Ruoqian ^b   Goodman Jr , Oscar B ^a   Nanus, David M ^a,b  

^a Genitourinary Oncology Service   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Androgen regulation; Androgen response element; Neutral endopeptidase; Prostate cancer

Indexed keywords

ANDROGEN; DEXAMETHASONE; MEMBRANE METALLOENDOPEPTIDASE; PROGESTERONE;

3' UNTRANSLATED REGION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOMICS; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MALE; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANDROGENS; BASE SEQUENCE; CELL EXTRACTS; CELL NUCLEUS; CELLS, CULTURED; DNA-BINDING PROTEINS; EXONS; GLUCOCORTICOIDS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; NEPRILYSIN; PROGESTERONE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION;

EID: 33748935383     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.07.004     Document Type: Article

References (47)

1. Auboeuf D., Dowhan D.H., Kang Y.K., Larkin K., Lee J.W., Berget S.M., and O'Malley B.W. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2270-2274
2. Borson D.B., and Gruenert D.C. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am. J. Physiol. 260 (1991) L83-L89
3. Casey M.L., Smith J.W., Nagai K., Hersh L.B., and MacDonald P.C. Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium. J. Biol. Chem. 266 (1991) 23041-23047
4. Chang Z.F., and Liu C.J. Human thymidine kinase CCAAT-binding protein is NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblasts. J. Biol. Chem. 269 (1994) 17893-17898
5. Cleutjens K.B., van der Korput H.A., van Eekelen C.C., van Rooij H.C., Faber P.W., and Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11 (1997) 148-161
6. Cleutjens K.B., van Eekelen C.C., van der Korput H.A., Brinkmann A.O., and Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem. 271 (1996) 6379-6388
7. D'Adamio L., Shipp M.A., Masteller E.L., and Reinherz E.L. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7103-7107
8. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., and Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7 (1987) 725-737
9. Freedland S.J., Seligson D.B., Liu A.Y., Pantuck A.J., Paik S.H., Horvath S., Wieder J.A., Zisman A., Nguyen D., Tso C.L., Palotie A.V., and Belldegrun A.S. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate 55 (2003) 71-80
10. Geserick C., Meyer H.A., Barbulescu K., and Haendler B. Differential modulation of androgen receptor action by deoxyribonucleic acid response elements. Mol. Endocrinol. 17 (2003) 1738-1750
11. Graf K., Koehne P., Grafe M., Zhang M., Auch-Schwelk W., and Fleck E. Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension 26 (1995) 230-235
12. Graf K., Schaper C., Grafe M., Fleck E., and Kunkel G. Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells. Basic Res. Cardiol. 93 (1998) 11-17
13. Haouas H., Morello D., Lavenu A., Billard M., Jasmin C., and Boucheix C. Characterization of the 5′ region of the CD10/neutral endopeptidase 24.11 gene. Biochem. Biophys. Res. Commun. 207 (1995) 933-942
14. Huang J., Guan H., Booze R.M., Eckman C.B., and Hersh L.B. Estrogen regulates neprilysin activity in rat brain. Neurosci. Lett. 367 (2004) 85-87
15. Ino K., Suzuki T., Uehara C., Nagasaka T., Okamoto T., Kikkawa F., and Mizutani S. The expression and localization of neutral endopeptidase 24.11/CD 10 in human gestational trophoblastic diseases. Lab. Invest. 80 (2000) 1729-1738
16. Ishimaru F., Mari B., and Shipp M.A. The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms. Blood 89 (1997) 4136-4145
17. Ishimaru F., and Shipp M.A. Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements. Blood 85 (1995) 3199-3207
18. Jain A., Lam A., Vivanco I., Carey M.F., and Reiter R.E. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol. Endocrinol. 16 (2002) 2323-2337
19. Kim Y.K., and Lee A.S. Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors. Mol. Cell. Biol. 11 (1991) 2296-2302
20. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucl. Acids Res. 29 (2001) 2905-2919
21. Klinge C.M., Jernigan S.C., Smith S.L., Tyulmenkov V.V., and Kulakosky P.C. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell. Endocrinol. 174 (2001) 151-166
22. Lefstin J.A., and Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 392 (1998) 885-888
23. Lin C.S., Lau A., Yeh C.C., Chang C.H., and Lue T.F. Upregulation of l-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences. DNA Cell Biol. 19 (2000) 1-7
24. Lonard D.M., and O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 30 (2005) 126-132
25. Osman I., Yee H., Taneja S.S., Levinson B., Zeleniuch-Jacquotte A., Chang C., Nobert C., and Nanus D.M. Neutral endopeptidase protein expression and prognosis in localized prostate cancer. Clin. Cancer Res. 10 (2004) 4096-4100
26. Palvimo J.J., Kallio P.J., Ikonen T., Mehto M., and Janne O.A. Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol. Endocrinol. 7 (1993) 1399-1407
27. Pang S., Dannull J., Kaboo R., Xie Y., Tso C.L., Michel K., deKernion J.B., and Belldegrun A.S. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res. 57 (1997) 495-499
28. Papandreou C.N., Usmani B., Geng Y., Bogenrieder T., Freeman R., Wilk S., Finstad C.L., Reuter V.E., Powell C.T., Scheinberg D., Magill C., Scher H.I., Albino A.P., and Nanus D.M. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat. Med. 4 (1998) 50-57
29. Patikoglou G.A., Kim J.L., Sun L., Yang S.H., Kodadek T., and Burley S.K. TATA element recognition by the TATA box-binding protein has been conserved throughout evolution. Genes Dev. 13 (1999) 3217-3230
30. Reid K.J., Hendy S.C., Saito J., Sorensen P., and Nelson C.C. Two classes of androgen receptor elements mediate cooperativity through allosteric interactions. J. Biol. Chem. 276 (2001) 2943-2952
31. Rennie P.S., Bruchovsky N., Leco K.J., Sheppard P.C., McQueen S.A., Cheng H., Snoek R., Hamel A., Bock M.E., MacDonald B.S., et al. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol. 7 (1993) 23-36
32. Roche P.J., Hoare S.A., and Parker M.G. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6 (1992) 2229-2235
33. Rosenberg D., Groussin L., Jullian E., Perlemoine K., Bertagna X., and Bertherat J. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann. N Y Acad. Sci. 968 (2002) 65-74
34. Saito T., Iwata N., Tsubuki S., Takaki Y., Takano J., Huang S.M., Suemoto T., Higuchi M., and Saido T.C. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med. 11 (2005) 434-439
35. Sezaki N., Ishimaru F., Tabayashi T., Kataoka I., Nakase K., Fujii K., Kozuka T., Nakayama H., Harada M., and Tanimoto M. The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5′-untranslated region. Br. J. Haematol. 123 (2003) 177-183
36. Shen R., Sumitomo M., Dai J., Hardy D.O., Navarro D., Usmani B., Papandreou C.N., Hersh L.B., Shipp M.A., Freedman L.P., and Nanus D.M. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Mol. Cell. Endocrinol. 170 (2000) 131-142
37. Shipp M.A., and Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!. Blood 82 (1993) 1052-1070
38. Sumitomo M., Shen R., and Nanus D.M. Involvement of neutral endopeptidase in neoplastic progression. Biochim. Biophys. Acta 1751 (2005) 52-59
39. Suzuki Y., Tsunoda T., Sese J., Taira H., Mizushima-Sugano J., Hata H., Ota T., Isogai T., Tanaka T., Nakamura Y., Suyama A., Sakaki Y., Morishita S., Okubo K., and Sugano S. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res. 11 (2001) 677-684
40. Tan J., Marschke K.B., Ho K.C., Perry S.T., Wilson E.M., and French F.S. Response elements of the androgen-regulated C3 gene. J. Biol. Chem. 267 (1992) 7958
41. Turner A.J., and Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. Faseb J. 11 (1997) 355-364
42. Usmani B.A., Harden B., Maitland N.J., and Turner A.J. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin. Sci. Lond. 103 Suppl. 48 (2002) 314S-317S
43. van der Velden V.H., Naber B.A., van der Spoel P., Hoogsteden H.C., and Versnel M.A. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. Cytokine 10 (1998) 55-65
44. Wood W.G. The complexities of beta globin gene regulation. Trends Genet. 12 (1996) 204-206
45. Wu J., Su G., Ma L., Zhang X., Lei Y., Li J., Lin Q., and Fang L. Protein kinases mediate increment of the phosphorylation of cyclic AMP-responsive element binding protein in spinal cord of rats following capsaicin injection. Mol. Pain 1 (2005) 26
46. Zellweger T., Ninck C., Mirlacher M., Annefeld M., Glass A.G., Gasser T.C., Mihatsch M.J., Gelmann E.P., and Bubendorf L. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 55 (2003) 20-29
47. Zenzie-Gregory B., Khachi A., Garraway I.P., and Smale S.T. Mechanism of initiator-mediated transcription: evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition sequence. Mol. Cell. Biol. 13 (1993) 3841-3849